Sumitovant Biopharma

Pharmaceutical development in Midtown often feels like an invisible force—quietly shaping the medicines that eventually reach clinics and pharmacies. Sumitovant Biopharma operates at this intersection, where research and regulatory pathways converge. The company’s presence on West 42nd Street places it within a district known for its concentration of corporate and scientific offices, a fitting backdrop for an organization focused on advancing therapeutic solutions.

Those tracking the sector may recognize the address: 151 W 42nd St New York, NY 10036. The building itself is part of the city’s dense vertical landscape, where floor after floor houses teams working on everything from clinical trials to market access strategies. While the work happens behind unassuming facades, the impact of pharmaceutical innovation often extends far beyond the block, influencing treatment options that become part of everyday healthcare.

For anyone needing to connect with the team, reaching out at (716) 235-5983 ext. is the simplest way to initiate contact. Directions to the office can be found on the map, which pinpoints the exact location amid the neighborhood’s mix of theaters, corporate towers, and transit hubs. The area’s constant hum of activity contrasts with the focused, methodical nature of the work inside.